Shi, H., Yu, F., Mao, Y., Ju, Q., Wu, Y., Bai, W., . . . Shi, J. (2018). EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma. J Thorac Dis.
Citación estilo ChicagoShi, Hui, et al. "EphA2 Chimeric Antigen Receptor-modified T Cells for the Immunotherapy of Esophageal Squamous Cell Carcinoma." J Thorac Dis 2018.
Cita MLAShi, Hui, et al. "EphA2 Chimeric Antigen Receptor-modified T Cells for the Immunotherapy of Esophageal Squamous Cell Carcinoma." J Thorac Dis 2018.
Precaución: Estas citas no son 100% exactas.